Drug Trial Radar · NCT05737121
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
May 22, 2023
Primary completion
Jun 2026
Study completion Jun 2026
Sponsor
- Lead sponsor
- Vaneltix Pharma, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Prevail Infoworks
- First posted
- Feb 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, prospective, randomized, double-blind, placebo-controlled, multi-center, single-dose, pharmacodynamic study designed to evaluate the efficacy and safety of the combination product (VNX001) versus placebo and its individual components (heparin sodium and lidocaine hydrochloride (HCl)) for the reduction of bladder pain in patients with interstitial cystitis (IC) / bladder pain syndrome (BPS), Who Have an Episode of Acute Bladder Pain of Moderate to Severe Intensity.
Conditions
- Interstitial Cystitis
- Bladder Pain Syndrome
Interventions
VNX001Drug
VNX001 (alkalinized lidocaine HCl and heparin sodium)
PlaceboDrug
Inactive placebo for VNX001
LidocaineDrug
Alkalinized lidocaine hydrochloride
HeparinDrug
Alkalinized heparin sodium
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sum of bladder pain intensity differences from baseline to 12 hours post-dose (SPID-12)Time frame: 12 hours
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
IC Study LLC
Escondido, California · Suspended
University of California Los Angeles Center for Women's Pelvic Health
Los Angeles, California · Completed
The Clark Center for Urogynecology
Newport Beach, California · Recruiting
The Continence Center Medical Group, Inc dba Southern California Continence Center
Newport Beach, California · Completed
University of California San Diego Medical Center
San Diego, California · Recruiting
Prestige Medical Group
Tustin, California · Recruiting
United Research Institute
Hialeah, Florida · Recruiting
Florida Urology Partners
Tampa, Florida · Recruiting
Georgia Urology
Cartersville, Georgia · Recruiting
Southern Clinical Research Associates LLC
Metairie, Louisiana · Recruiting
Bay State Clinical Trials
Watertown, Massachusetts · Recruiting
Sheldon Freedman MD LTD
Las Vegas, Nevada · Recruiting
Northwell Health
Lake Success, New York · Recruiting
The Wake Forest Institute of Regenerative Medicine
Winston-Salem, North Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.